Prelude Therapeutics Statistics
Total Valuation
PRLD has a market cap or net worth of $465.54 million. The enterprise value is $331.43 million.
| Market Cap | 465.54M |
| Enterprise Value | 331.43M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PRLD has 102.99 million shares outstanding. The number of shares has increased by 10.91% in one year.
| Current Share Class | 65.08M |
| Shares Outstanding | 102.99M |
| Shares Change (YoY) | +10.91% |
| Shares Change (QoQ) | +19.23% |
| Owned by Insiders (%) | 4.38% |
| Owned by Institutions (%) | 20.23% |
| Float | 22.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.26 |
| Forward PS | 42.79 |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.13.
| Current Ratio | 4.07 |
| Quick Ratio | 3.99 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.73% and return on invested capital (ROIC) is -33.70%.
| Return on Equity (ROE) | -57.73% |
| Return on Assets (ROA) | -27.15% |
| Return on Invested Capital (ROIC) | -33.70% |
| Return on Capital Employed (ROCE) | -43.68% |
| Weighted Average Cost of Capital (WACC) | 9.19% |
| Revenue Per Employee | $283,848 |
| Profits Per Employee | -$765,671 |
| Employee Count | 79 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +295.58% in the last 52 weeks. The beta is 0.96, so PRLD's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +295.58% |
| 50-Day Moving Average | 5.03 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 35.12 |
| Average Volume (20 Days) | 544,467 |
Short Selling Information
The latest short interest is 3.59 million, so 3.49% of the outstanding shares have been sold short.
| Short Interest | 3.59M |
| Short Previous Month | 3.82M |
| Short % of Shares Out | 3.49% |
| Short % of Float | 16.28% |
| Short Ratio (days to cover) | 6.94 |
Income Statement
In the last 12 months, PRLD had revenue of $22.42 million and -$60.49 million in losses. Loss per share was -$0.72.
| Revenue | 22.42M |
| Gross Profit | 22.42M |
| Operating Income | -66.10M |
| Pretax Income | -60.49M |
| Net Income | -60.49M |
| EBITDA | -64.51M |
| EBIT | -66.10M |
| Loss Per Share | -$0.72 |
Balance Sheet
The company has $151.76 million in cash and $17.65 million in debt, with a net cash position of $134.11 million or $1.30 per share.
| Cash & Cash Equivalents | 151.76M |
| Total Debt | 17.65M |
| Net Cash | 134.11M |
| Net Cash Per Share | $1.30 |
| Equity (Book Value) | 133.73M |
| Book Value Per Share | 1.30 |
| Working Capital | 116.86M |
Cash Flow
| Operating Cash Flow | -33.26M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.59M |
| Net Borrowing | n/a |
| Free Cash Flow | -33.26M |
| FCF Per Share | -$0.32 |
Margins
Gross margin is 100.00%, with operating and profit margins of -294.76% and -269.75%.
| Gross Margin | 100.00% |
| Operating Margin | -294.76% |
| Pretax Margin | -269.75% |
| Profit Margin | -269.75% |
| EBITDA Margin | -287.68% |
| EBIT Margin | -294.76% |
| FCF Margin | n/a |
Dividends & Yields
PRLD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.91% |
| Shareholder Yield | -10.91% |
| Earnings Yield | -13.32% |
| FCF Yield | -7.32% |
Analyst Forecast
The average price target for PRLD is $8.00, which is 76.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 76.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 154.45% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRLD has an Altman Z-Score of -3.26 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.26 |
| Piotroski F-Score | 3 |